Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Iovance Biotherapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 295
- +26 vs. Q1 2024
- Shares held
- 232.5M
- +17.3M (+8.0%) vs. Q1 2024
- Total value
- $1.86B
- −$1.32B (−41.5%) vs. Q1 2024
- New holders
- 67
- 115 more added
- Sold out
- 41
- 80 more reduced
4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EAM Investors, LLC | 0 | $0 | 0.00% | −213,336−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −182,765−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −167,959−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −140,325−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −122,053−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −116,951−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −112,262−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −90,267−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −84,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −80,583−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −61,225−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −29,005−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −25,233−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −24,644−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −23,400−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −21,900−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −20,800−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −20,077−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −18,510−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −16,250−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −12,474−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −11,106−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,030−100.0% | Sold out |
| J.W. Cole Advisors, Inc. | 0 | $0 | 0.00% | −10,577−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −10,250−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −10,250−100.0% | Sold out |
| Harvest Fund Management Co., Ltd | 0 | $0 | 0.00% | −4,208−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −5,100−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Old Point Trust & Financial Services N A | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |
| Retirement Group, LLC | – | – | – | – | Not filed |